Trial Profile
Evaluation of the effect of cabergoline (dopamine receptor agonist) on the size and symptoms of uterine myoma in women with myoma
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 May 2017
Price :
$35
*
At a glance
- Drugs Cabergoline (Primary)
- Indications Uterine leiomyoma
- Focus Therapeutic Use
- 15 May 2017 New trial record